# | Title | Journal | Year | Citations |
---|
1 | Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | New England Journal of Medicine | 2011 | 2,491 |
2 | Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry | European Journal of Heart Failure | 2013 | 533 |
3 | Acute Myocardial Infarction | Circulation | 2017 | 352 |
4 | EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) | European Journal of Heart Failure | 2010 | 340 |
5 | Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography | Journal of the American College of Cardiology | 2009 | 323 |
6 | Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis | Journal of the American College of Cardiology | 2008 | 255 |
7 | Influence of Preoperative Left Ventricular Contractile Reserve on Postoperative Ejection Fraction in Low-Gradient Aortic Stenosis | Circulation | 2006 | 248 |
8 | Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document | European Journal of Heart Failure | 2013 | 182 |
9 | Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction | New England Journal of Medicine | 2021 | 172 |
10 | Differentiation In Vivo of Cardiac Committed Human Embryonic Stem Cells in Postmyocardial Infarcted Rats | Stem Cells | 2007 | 141 |
11 | Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications | European Heart Journal | 2016 | 137 |
12 | Periprocedural myocardial infarction and injury in elective coronary stenting | European Heart Journal | 2018 | 136 |
13 | Precipitating factors and 90‐day outcome of acute heart failure: a report from the intercontinental GREAT registry | European Journal of Heart Failure | 2017 | 126 |
14 | Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement | Journal of the American College of Cardiology | 2015 | 116 |
15 | Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study | British Journal of Haematology | 2016 | 113 |
16 | Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta‐Analysis, and New Insights From the CLOSE Study | Journal of the American Heart Association | 2018 | 112 |
17 | Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency | Journal of the American College of Cardiology | 2014 | 102 |
18 | Performance Analysis of EuroSCORE II Compared to the Original Logistic EuroSCORE and STS Scores for Predicting 30-Day Mortality After Transcatheter Aortic Valve Replacement | American Journal of Cardiology | 2013 | 101 |
19 | Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials | European Heart Journal | 2022 | 92 |
20 | Hyperkalemia in Heart Failure | Journal of the American College of Cardiology | 2016 | 86 |
21 | Heart failure in left‐sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment | European Journal of Heart Failure | 2009 | 80 |
22 | Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease | European Journal of Heart Failure | 2012 | 72 |
23 | Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges | International Journal of Cardiology | 2013 | 67 |
24 | Eplerenone and new‐onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS‐HF) | European Journal of Heart Failure | 2012 | 59 |
25 | Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study | Heart | 2010 | 57 |
26 | Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation | Journal of the American College of Cardiology | 2016 | 42 |
27 | Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study | European Heart Journal | 2021 | 38 |
28 | Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial | Catheterization and Cardiovascular Interventions | 2019 | 35 |
29 | Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist’s view | EuroIntervention | 2014 | 35 |
30 | High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry | Atherosclerosis | 2018 | 33 |
31 | Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme | European Heart Journal | 2020 | 32 |
32 | Long-Term Effects of Cicletanine on Secondary Pulmonary Hypertension | Journal of Cardiovascular Pharmacology | 1998 | 32 |
33 | Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study | European Journal of Clinical Pharmacology | 2015 | 31 |
34 | Anticoagulation in heart failure: current status and future direction | Heart Failure Reviews | 2013 | 28 |
35 | Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study | European Heart Journal | 2013 | 27 |
36 | Emerging cardiovascular indications of mineralocorticoid receptor antagonists | Trends in Endocrinology and Metabolism | 2015 | 27 |
37 | Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure | European Journal of Heart Failure | 2014 | 25 |
38 | Agents with vasodilator properties in acute heart failure: how to design successful trials | European Journal of Heart Failure | 2015 | 24 |
39 | When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches | Circulation: Heart Failure | 2012 | 23 |
40 | Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study | European Heart Journal Cardiovascular Imaging | 2022 | 22 |
41 | Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study | Addiction | 2022 | 22 |
42 | Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk | Clinical Cardiology | 2018 | 21 |
43 | Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015 | American Heart Journal | 2019 | 20 |
44 | Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? | European Heart Journal | 2012 | 19 |
45 | Adverse effects of benfluorex on heart valves and pulmonary circulation | Pharmacoepidemiology and Drug Safety | 2014 | 17 |
46 | Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy | Atherosclerosis | 2020 | 17 |
47 | Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study | Atherosclerosis Plus | 2021 | 17 |
48 | CD11b+ leukocyte microparticles are associated with high‐risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromes | Journal of Thrombosis and Haemostasis | 2011 | 16 |
49 | Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group | ESC Heart Failure | 2021 | 14 |
50 | Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program | Journal of Clinical Lipidology | 2020 | 13 |